BRCA1 and BRCA2 Genetic Testing are Dramatically Changing Prostate Cancer Treatment Options
Neal D. Shore, MD, FACS of Carolina Urologic Research Center explains how BRCA1 and BRCA2 genetic testing are significantly changing how prostate cancer should be treated. He believes that guidelines ...
Author: obr
Added: 03/01/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 1, 2017 Category: Cancer & Oncology Source Type: podcasts
ASCO GU 2017: Prostate Cancer Research Overview
Freddie C. Hamdy, MD of University of Oxford gives an overview of the new research that was discussed regarding prostate cancer at the 2017 Genitourinary Cancers Symposium (ASCO GU) in Orlando, Florid...
Author: obr
Added: 02/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 24, 2017 Category: Cancer & Oncology Source Type: podcasts
Side Effects of Surgery, Radiation, and Active Surveillance: Choosing One Over the Other for Patients
Freddie C. Hamdy, MD of University of Oxford gives his take on which choice would warrant over the others when it comes to their difference in side effects for patients with metastatic prostate cancer...
Author: obr
Added: 02/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 24, 2017 Category: Cancer & Oncology Source Type: podcasts
ASCO GU 2017: Design of the ProtecT Study
Freddie C. Hamdy, MD of University of Oxford gives an overview of how the ProtecT study was designed for prostate cancer research at 2017 Genitourinary Cancers Symposium (ASCO GU) in Orlando, Florida.
Author: obr
Added: 02/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 24, 2017 Category: Cancer & Oncology Source Type: podcasts
Photodynamic Therapy for Prostate Cancer Shows Early Promise
Initial study results using photodynamic therapy for shrinking prostate cancer size are promising and demonstrate the need for studies with longer follow-up and larger study groups. (Source: Medscape Urology Podcast)
Source: Medscape Urology Podcast - February 24, 2017 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
Should BRCA1 and BRCA2 Genetic Testing Be Added to Guidelines for Prostate Cancer
Ana Aparicio, MD of MD Anderson Cancer Center discusses her opinion on whether or not BRCA1 and BRCA2 genetic testing should be added to guidelines for prostate cancer treatment at the 2017 Genitourin...
Author: obr
Added: 02/23/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 23, 2017 Category: Cancer & Oncology Source Type: podcasts
How to Sequence Commonly Used Agents in Metastatic Prostate Cancer
Ana Aparicio, MD of MD Anderson Cancer Center gives her perspective on how to sequence commonly used agents in prostate cancer at the 2017 Genitourinary Cancers Symposium (ASCO GU) in Orlando, Florida...
Author: obr
Added: 02/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 22, 2017 Category: Cancer & Oncology Source Type: podcasts
Will Immunotherapy Be Used for Metastatic Prostate Cancer Treatment in the Near Future
Ana Aparicio, MD of MD Anderson Cancer Center gives her take on whether immunotherapy will be added to treatment guidelines for prostate cancer in the near future at the 2017 Genitourinary Cancers Sym...
Author: obr
Added: 02/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 22, 2017 Category: Cancer & Oncology Source Type: podcasts
CHAARTED and STAMPEDE Impacting Treatment for Metastatic Hormone Sensitive Prostate Cancer Patients
Ana Aparicio, MD of MD Anderson Cancer Center discusses how the CHARTED and STAMPEDE trials impacted her treatment for patients with metastatic hormone sensitive prostate cancer at the 2017 Genitourin...
Author: obr
Added: 02/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 22, 2017 Category: Cancer & Oncology Source Type: podcasts
Where Does Chemotherapy Fit Into Prostate Cancer Treatment
Ana Aparicio, MD of MD Anderson Cancer Center discusses how and where does chemotherapy fit for treating patients with prostate cancer at the 2017 Genitourinary Cancers Symposium (ASCO GU) in Orlando,...
Author: obr
Added: 02/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 22, 2017 Category: Cancer & Oncology Source Type: podcasts
Chemotherapy for Metastatic Castration-Resistant Prostate Patients
Ana Aparicio, MD of MD Anderson Cancer Center gives her take on which prostate cancer patients should be treated with chemotherapy at the 2017 Genitourinary Cancers Symposium (ASCO GU) in Orlando, Flo...
Author: obr
Added: 02/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 22, 2017 Category: Cancer & Oncology Source Type: podcasts
Use of MRI in prostate cancer screening: The Lancet: January 19, 2017
Hashim Ahmed discusses his study about the diagnostic accuracy of multi-parametric MRI in detecting clinically significant prostate cancer in men. (Source: Listen to The Lancet)
Source: Listen to The Lancet - January 20, 2017 Category: General Medicine Authors: The Lancet Source Type: podcasts
Improving Androgen-Deprivation Therapy for Prostate Cancer
Dr. David Goodrich, Professor of Oncology at Roswell Park Cancer Institute, is co-author of a study offering new insights on preventing androgen-deprivation therapy resistance for prostate cancer. The...
Author: roswellpark
Added: 01/06/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 6, 2017 Category: Cancer & Oncology Source Type: podcasts
